Last reviewed · How we verify

NCT03447028: TyG-PCa

Effect of TyG Index on Outcomes of Radical Prostatectomy

Completed Last updated 27 February 2018
What this trial tests

trial in Metabolic Syndrome in 200 participants. Completed in 30 December 2012.

Timeline
1 January 2007
Primary endpoint
30 December 2012
30 December 2012

Quick facts

Lead sponsorRecep Tayyip Erdogan University Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date1 January 2007
Primary completion30 December 2012
Estimated completion30 December 2012

Conditions studied

Sponsor

Recep Tayyip Erdogan University Training and Research Hospital

Who can join

Eligibility, male only, with Metabolic Syndrome or Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We investigate the association between Triglyserid-Glucose(TyG) index and prostate cancer in patients undergoing radical prostatectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Metabolic Syndrome

Currently open trials in the same condition.

Other Recep Tayyip Erdogan University Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03447028.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing